Airway basal cells. The "smoking gun" of chronic obstructive pulmonary disease.
| Publication Type | Academic Article |
| Authors | Crystal R |
| Journal | Am J Respir Crit Care Med |
| Volume | 190 |
| Issue | 12 |
| Pagination | 1355-62 |
| Date Published | 12/15/2014 |
| ISSN | 1535-4970 |
| Keywords | Pulmonary Disease, Chronic Obstructive, Stem Cells |
| Abstract | The earliest abnormality in the lung associated with smoking is hyperplasia of airway basal cells, the stem/progenitor cells of the ciliated and secretory cells that are central to pulmonary host defense. Using cell biology and 'omics technologies to assess basal cells isolated from bronchoscopic brushings of nonsmokers, smokers, and smokers with chronic obstructive pulmonary disease (COPD), compelling evidence has been provided in support of the concept that airway basal cells are central to the pathogenesis of smoking-associated lung diseases. When confronted by the chronic stress of smoking, airway basal cells become disorderly, regress to a more primitive state, behave as dictated by their inheritance, are susceptible to acquired changes in their genome, lose the capacity to regenerate the epithelium, are responsible for the major changes in the airway that characterize COPD, and, with persistent stress, can undergo malignant transformation. Together, these observations led to the conclusion that accelerated loss of lung function in susceptible individuals begins with disordered airway basal cell biology (i.e., that airway basal cells are the "smoking gun" of COPD, a potential target for the development of therapies to prevent smoking-related lung disorders). |
| DOI | 10.1164/rccm.201408-1492PP |
| PubMed ID | 25354273 |
| PubMed Central ID | PMC4299651 |